Oncology Pipeline
PharmaMar in the World
Other Businesses
Biopharmaceutical Sector
 |
 |
Investors
PharmaMar provides you all the financial information possible regarding our activities on the BME exchange, historical quarterly and annual information.
- 26/06/2019 Composition of the board of directors
- 26/06/2019 Transmissions and purchases of capital undertakings
- 26/06/2019 Announcements and resolutions of general shareholders meetings
- 26/06/2019 Strategic plans, profit forecasts and presentations
- 01/06/2019 R&D: new licenses, patents and registered trademarks
- 23/05/2019 Announcements and resolutions of general shareholders meetings
- 23/05/2019 Transmissions and purchases of capital undertakings
- 16/05/2019 R&D: new licenses, patents and registered trademarks
- 15/05/2019 R&D: new licenses, patents and registered trademarks
- 26/04/2019 Credit ratings
- 26/04/2019 Information on P&L
- 26/04/2019 Strategic agreements with third parties
- 04/04/2019 Liquidity contracts and specialists
- 01/04/2019 R&D: new licenses, patents and registered trademarks
- 25/03/2019 R&D: new licenses, patents and registered trademarks
- 29/02/2019 Announcements of public presentations and meetings
- 28/02/2019 Information on P&L
-
Financial
Information -
PharmaMar provides you all the financial information possible regarding our activities on the BME exchange, historical quarterly and annual information.
-
Official Notices
to the CNMV -
- 26/06/2019 Composition of the board of directors
- 26/06/2019 Transmissions and purchases of capital undertakings
- 26/06/2019 Announcements and resolutions of general shareholders meetings
- 26/06/2019 Strategic plans, profit forecasts and presentations
- 01/06/2019 R&D: new licenses, patents and registered trademarks
- 23/05/2019 Announcements and resolutions of general shareholders meetings
- 23/05/2019 Transmissions and purchases of capital undertakings
- 16/05/2019 R&D: new licenses, patents and registered trademarks
- 15/05/2019 R&D: new licenses, patents and registered trademarks
- 26/04/2019 Credit ratings
- 26/04/2019 Information on P&L
- 26/04/2019 Strategic agreements with third parties
- 04/04/2019 Liquidity contracts and specialists
- 01/04/2019 R&D: new licenses, patents and registered trademarks
- 25/03/2019 R&D: new licenses, patents and registered trademarks
- 29/02/2019 Announcements of public presentations and meetings
- 28/02/2019 Information on P&L
-
Share
Information -
Corporate
Presentations
Contact
PHARMA MAR, S.A.
Avda. de los Reyes, 1
Pol. Ind. La Mina, 28770
Colmenar Viejo, Madrid, Spain
VAT: ESA-78267176
|
|
|
|
If you wish to inform on an adverse event, please click here
#AbreLosOjosAlSarcoma Hoy @CrisGarridoP publica las principales conclusiones en @abc_salud del encuentro que celebramos junto a @AEASARCOMA, la #FundacionMariPazJiménezCasado y el oncólogo especializado en #sarcoma con motivo del #DíaNacionalDelSarcoma.
https://t.co/nLmALcIBAP
Pharmamar organizó ayer una jornada con motivo del #DíaNacionalDelSarcoma que reunió a expertos y asociaciones de pacientes para concienciar y actualizar datos sobre esta enfermedad bajo el lema #AbreLosOjosAlSarcoma. #Trabectedina @AEASARCOMA
https://t.co/bbmATix73C
#Innovation is not a resource, it is a capacity that allows us to realize things that previously existed only in our imagination.
We fight against #cancer using this type #innovation #InnovativeOncology https://t.co/dDvRiwd55a
Newsletter
Subscribe to our newsletter and you will receive the latest news about PharmaMar, information about new advances, data for investors, and much more.